Literature DB >> 25712990

Diagnostic approach to von Willebrand disease.

Christopher Ng1, David G Motto2, Jorge Di Paola1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25712990      PMCID： PMC4375103          DOI： 10.1182/blood-2014-08-528398

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  69 in total

1.  The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

Authors:  M Laffan; S A Brown; P W Collins; A M Cumming; F G H Hill; D Keeling; I R Peake; K J Pasi
Journal:  Haemophilia       Date:  2004-05       Impact factor: 4.287

2.  Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.

Authors:  Z M Ruggeri; F I Pareti; P M Mannucci; N Ciavarella; T S Zimmerman
Journal:  N Engl J Med       Date:  1980-05-08       Impact factor: 91.245

3.  Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.

Authors:  T Quiroga; M Goycoolea; B Muñoz; M Morales; E Aranda; O Panes; J Pereira; D Mezzano
Journal:  J Thromb Haemost       Date:  2004-06       Impact factor: 5.824

4.  von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.

Authors:  J L Miller; J M Kupinski; A Castella; Z M Ruggeri
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

5.  Substructure of human von Willebrand factor.

Authors:  W E Fowler; L J Fretto; K K Hamilton; H P Erickson; P A McKee
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  The effect of ABO blood group on the diagnosis of von Willebrand disease.

Authors:  J C Gill; J Endres-Brooks; P J Bauer; W J Marks; R R Montgomery
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

7.  Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L H Nolasco; J D Hellums
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

8.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

9.  Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

Authors:  T S Zimmerman; J A Dent; Z M Ruggeri; L H Nannini
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

10.  A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity.

Authors:  R R Montgomery; W E Hathaway; J Johnson; L Jacobson; W Muntean
Journal:  Blood       Date:  1982-07       Impact factor: 22.113
View more
  34 in total

1.  An international survey to inform priorities for new guidelines on von Willebrand disease.

Authors:  Mohamad A Kalot; Mohammed Al-Khatib; Nathan T Connell; Veronica Flood; Romina Brignardello-Petersen; Paula James; Reem A Mustafa
Journal:  Haemophilia       Date:  2019-11-26       Impact factor: 4.287

Review 2.  Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Authors:  Piercarla Schinco; Giancarlo Castaman; Antonio Coppola; Dorina Cultrera; Cosimo Ettorre; Anna C Giuffrida; Emanuela Marchesini; Renato Marino; Marta Milan; Claudio Molinari; Simona M Siboni; Ezio Zanon; Augusto B Federici
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

Review 3.  From structure to redox: The diverse functional roles of disulfides and implications in disease.

Authors:  Tyler J Bechtel; Eranthie Weerapana
Journal:  Proteomics       Date:  2017-03       Impact factor: 3.984

4.  Establishment of an International Reference Reagent for standardization of von Willebrand factor binding to recombinant glycoprotein Ib (VWF:GPIbM and VWF:GPIbR): Official Communication of the SSC.

Authors:  Anthony R Hubbard; Sandra L Haberichter
Journal:  J Thromb Haemost       Date:  2019-05-17       Impact factor: 5.824

Review 5.  Platelets in liver and renal disease.

Authors:  Michele P Lambert
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Single-cell transcriptional analysis of human endothelial colony-forming cells from patients with low VWF levels.

Authors:  Christopher J Ng; Alice Liu; Sujatha Venkataraman; Katrina J Ashworth; Christopher D Baker; Rebecca O'Rourke; Rajeev Vibhakar; Kenneth L Jones; Jorge Di Paola
Journal:  Blood       Date:  2022-04-07       Impact factor: 22.113

7.  Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.

Authors:  M Lehmann; K Ashworth; M Manco-Johnson; J Di Paola; K B Neeves; C J Ng
Journal:  J Thromb Haemost       Date:  2017-11-23       Impact factor: 5.824

8.  Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort.

Authors:  Elizabeth M Kander; Sania Raza; Zheng Zhou; Juehua Gao; Anaadriana Zakarija; Brandon J McMahon; Brady L Stein
Journal:  Int J Hematol       Date:  2015-10-06       Impact factor: 2.490

9.  Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract.

Authors:  Hanna Allerkamp; Stefanie Lehner; Mahnaz Ekhlasi-Hundrieser; Carsten Detering; Christiane Pfarrer; Mario von Depka Prondzinski
Journal:  Comp Med       Date:  2019-09-16       Impact factor: 0.982

10.  von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C.

Authors:  Hiroaki Takaya; Hideto Kawaratani; Yuki Tsuji; Keisuke Nakanishi; Soichiro Saikawa; Shinya Sato; Yasuhiko Sawada; Kosuke Kaji; Yasushi Okura; Naotaka Shimozato; Mitsuteru Kitade; Takemi Akahane; Kei Moriya; Tadashi Namisaki; Akira Mitoro; Masanori Matsumoto; Hiroshi Fukui; Hitoshi Yoshiji
Journal:  United European Gastroenterol J       Date:  2018-05-25       Impact factor: 4.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.